UK markets close in 6 hours 41 minutes
Interest rates

Bank of England set to raise base rates to 4%

Central banks in UK, Europe and the US all set to raise rates

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.7800+0.0400 (+2.30%)
At close: 04:00PM EST
1.7700 -0.01 (-0.56%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.7400
Open1.7300
Bid0.0000 x 1400
Ask0.0000 x 1800
Day's range1.7191 - 1.7900
52-week range1.4500 - 6.3200
Volume778,888
Avg. volume1,459,705
Market cap295.258M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    New Regulations for Psychedelics? Here's What Investors Need to Know

    If you love investing in businesses that are on the bleeding edge of biotechnology, psychedelics companies are right up your alley. Despite substantial cultural baggage and significant legal hurdles, psychedelic medicines are proving themselves to be highly effective at treating mental illnesses like depression and post-traumatic stress disorder (PTSD), and that means they're likely to be quite lucrative for the developers. On July 13, the Drug Enforcement Agency (DEA) said it was scheduling a public hearing for Aug. 22, so people would have a chance to comment on a proposed rule that would move five psychedelic compounds into the Schedule 1 category.

  • Simply Wall St.

    Here's Why We're Not Too Worried About Atai Life Sciences' (NASDAQ:ATAI) Cash Burn Situation

    We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...